Branded companies slowing generic drugs' path to market: FDA's Scott Gottlieb

Scott Gottlieb, Food and Drug Administration commissioner, talks about looking at ways to improve the generic drug approval process, issues of drug pricing and competition, and addressing the opioid crisis.